dokumen.tips_parameter-farmakokinetik-5785c20de078f.ppt
Download as PPT, PDF0 likes37 views
The document discusses the importance of pharmacokinetic parameters in drug therapy. It describes key parameters like volume of distribution, clearance, half-life, and how they can be used to determine dosing regimens. Volume of distribution relates the amount of drug in the body to its concentration in blood. Clearance predicts the rate of drug elimination based on its concentration. Half-life is the time for the drug amount in the body to reduce by half. These parameters along with target concentration can be used to calculate loading and maintenance doses to achieve a rational dosage regimen. Disease states can impact pharmacokinetic parameters by altering clearance, volume of distribution and half-life.
1 of 12
Download to read offline
Recommended
Expt. 13 Calculation of pharmacokinetic parameters from a given data
Expt. 13 Calculation of pharmacokinetic parameters from a given dataVISHALJADHAV100
油
Objective
Pharmacokinetics (PKs) and Clinical Pharmacokinetics
Plasma Drug Concentration-Time Profile
Peak Plasma Concentration (Cmax)
Time of Peak Concentration (tmax)
Area Under the Curve (AUC)
Bioavailability (BA)
Volume of Distribution (Vd)
Half-Life (t1/2)
Clearance (CL)
Loading and Maintenance Dose
Result and interpretationpharmacokinetic of iv infusion
pharmacokinetic of iv infusionDr.saqib habib
油
The document discusses pharmacokinetics of intravenous drug infusion. It describes how a drug administered via constant IV infusion will reach a steady state plasma concentration determined by the infusion rate and drug clearance. It also discusses factors that affect this steady state concentration and the time required to reach it, such as volume of distribution and elimination half-life. Compartmental models including one, two, and multi-compartment models are introduced to explain drug distribution and elimination kinetics over time.SUSTAINDRUG DELIVERY SYSTEMS power point
SUSTAINDRUG DELIVERY SYSTEMS power pointSonam Gandhi
油
This document provides an overview of a seminar presentation on sustained release drug delivery systems. Some key points discussed include:
1. Sustained release drug delivery systems are designed to provide prolonged therapeutic effects by continuously releasing medication over an extended period after a single dose.
2. Factors that influence the suitability of a drug for sustained release formulations include its absorption, distribution, metabolism, and biological half-life properties.
3. The document outlines various physiological and physicochemical drug properties that must be considered when designing sustained release drug formulations, such as dosage size, solubility, and stability.Pharmacokinetics ppt
Pharmacokinetics pptsigma institute of pharmacy
油
The document summarizes key concepts in pharmacokinetics including biological half-life, volume of distribution, renal clearance, total body clearance, plasma protein binding, absorption and elimination rate constants. Pharmacokinetics is the study of the movement of drugs in the body over time, including absorption, distribution, metabolism and excretion. It involves experimental measurement of drug concentrations as well as theoretical modeling of drug disposition.Pharmacokinetics ppt
Pharmacokinetics pptsigma institute of pharmacy
油
The document summarizes key concepts in pharmacokinetics including biological half-life, volume of distribution, renal clearance, total body clearance, plasma protein binding, absorption and elimination rate constants. Pharmacokinetics is the study of the movement of drugs in the body over time, including absorption, distribution, metabolism and excretion. It involves experimental measurement of drug concentrations as well as theoretical modeling of drug disposition.Pharmacokinetic parameters
Pharmacokinetic parametersDeepakPandey379
油
This document discusses various pharmacokinetic parameters including absorption, distribution, metabolism, excretion, and dosing regimens. It defines key terms like bioavailability, volume of distribution, clearance, half-life, and therapeutic drug monitoring. Factors that influence these parameters like protein binding, blood flow, and drug interactions are also covered. The relationships between concepts like clearance, volume of distribution, half-life, and how they impact dosing are explained through mathematical equations.sustained release drug delivery system
sustained release drug delivery systemprashant mane
油
A drug delivery system that are design to achieve prolonged therapeutic action over an extended period of time on single dose.Chapter 4 BA.pptx for biopharmaceuticall
Chapter 4 BA.pptx for biopharmaceuticallShakirAliyi
油
Unfortunately I have all identity and no other means of doing so I will assume it means the risk of contracting disease X was the same for both sexes and the actual burden of the particular disease and the multifactorial model recognizes that most diseases are transmitted through the invasion and growth of specific pathogens in the body is to help maintain normal levels of fluid inside our cells Source of chloride the Western diet are sodium chloride and the multifactorial model recognizes that most diseases are transmitted through the invasion and growth of specific pathogens in the body is to help maintain normal levels of fluid inside our cells Source of chloride the Western diet are sodium chloride and the multifactorial model recognizes that most diseases are transmitted transmitted the the the the of specific pathogens in in body is to to maintain normal normal of of inside our our Source of chloride the Western Western are sodium sodium and the multifactorial model model that most diseases are transmitted transmitted transmitted transmitted transmitted transmitted of specific pathogens in the body is to help maintain normal levels of fluid inside our cells Source of chloride the Western diet are sodium chloride and the multifactorial model recognizes that most diseases are transmitted through the invasion and growth of specific pathogens in the body is to help maintain normal levels of fluid inside our cells Source of chloride the Western diet are sodium chloride and the multifactorial model recognizes that most diseases are transmitted through the invasion and growth of specific pathogens in the body Chapter 4 BA.biopharamaceutical ppt .com
Chapter 4 BA.biopharamaceutical ppt .comShakirAliyi
油
Heres a detailed breakdown of the sections of a business plan tailored specifically to an Oromia-themed restaurant and coffee shop:
---
### **1. Executive Summary**
**Purpose**: Provides a snapshot of the business idea and captures the interest of potential investors or stakeholders.
#### **Key Elements**:
- **Business Name**: Oromia Restaurant & Coffee Shop.
- **Mission Statement**: "To deliver an authentic Oromia cultural and culinary experience by offering high-quality traditional dishes and coffee in a welcoming atmosphere."
- **Business Goals**:
- Launch and establish a leading Oromia-themed restaurant and coffee shop within one year.
- Achieve monthly revenue growth of 15% within the first two years.
- **Target Audience**: Ethiopian diaspora, cultural enthusiasts, coffee lovers, and foodies seeking authentic Oromo cuisine.
- **Funding Requirements**: $200,000 for startup costs (kitchen equipment, interior design, marketing, and initial operations).
---
### **2. Business Description**
**Purpose**: Explains what the business is, its purpose, and its unique qualities.
#### **Key Elements**:
- **Industry Overview**: Focused on the Ethiopian culinary and hospitality industry, with special emphasis on Oromo culture and coffee traditions.
- **Business Concept**: A fusion of restaurant and coffee shop offering authentic Oromo dishes, specialty coffee ceremonies, and cultural performances.
- **Unique Selling Proposition (USP)**: A niche cultural dining experience combining Oromo cuisine, freshly roasted coffee, and immersive cultural elements like music and decor.
---
### **3. Market Analysis**
**Purpose**: Understands the market and identifies opportunities.
#### **Key Elements**:
- **Target Market**:
- Local residents in urban areas who appreciate diverse cuisines.
- Ethiopian/Oromo diaspora interested in cultural preservation.
- Tourists seeking authentic experiences.
- **Market Trends**:
- Growing interest in Ethiopian cuisine globally.
- Increasing demand for specialty coffee experiences.
- Cultural dining as a growing niche in the hospitality industry.
- **Competitor Analysis**:
- Competing restaurants: Focused on general Ethiopian dishes.
- Differentiation: Highlight unique Oromo flavors and traditional coffee ceremonies.
---
### **4. Organization and Management**
**Purpose**: Outlines the structure and key personnel.
#### **Key Elements**:
- **Ownership Structure**: Sole proprietorship or partnership owned by Oromo entrepreneurs.
- **Management Team**:
- General Manager: Overseeing operations and finance.
- Head Chef: Specializing in Oromo dishes.
- Barista Lead: Expert in coffee brewing and ceremony presentations.
- Marketing Manager: Focus on community outreach and promotions.
---
### **5. Products and Services**
**Purpose**: Describes the offerings in detail.
#### **Key Elements**:
- **Menu Items**:
- Signature Dishes: Injera with Chapter 4 biopharmaceutical and therapy ppt
Chapter 4 biopharmaceutical and therapy pptShakirAliyi
油
Of the findings of the distribution of a policy being made to the need of the key to be made to be removed enzymatically the information provided is the study is prevalence by the number to be scientific and used of its counterpart and its transmission of information to others and is also applicable laws to be scientific or used in accordance with metabolism and other legumes and other legumes and other legumes to make hemoglobin and all the group 3Bioavailability and bioequivalence of Drug Product.docx
Bioavailability and bioequivalence of Drug Product.docxabhisheksinghcompute
油
This document discusses bioavailability and bioequivalence of drug products. It defines bioavailability as the proportion of a drug that is absorbed and available systemically, and bioequivalence as assessing the expected in vivo equivalence of two drug preparations. Two products are considered bioequivalent if their bioavailability and effects are essentially the same. Pharmacokinetic methods like plasma level time studies and pharmacodynamic methods are used to measure bioavailability. Key parameters analyzed from plasma concentration-time curves include Cmax, Tmax, and AUC.BioavailabilityandBioequivalence.pdf
BioavailabilityandBioequivalence.pdfabhisheksinghcompute
油
This document discusses bioavailability and bioequivalence. It defines bioavailability as the rate and extent of absorption of an orally administered drug, which depends on factors like absorption and hepatic metabolism. Bioequivalence refers to similar bioavailability between formulations, and is determined by comparing AUC and Cmax values. The document outlines methods to assess bioavailability, including pharmacokinetic studies and dissolution testing, and factors that can influence bioavailability such as physiological, physicochemical, and pharmacological factors. It also discusses limitations of bioavailability and bioequivalence studies.lecture 4 Clinical pharmacokinetics.pptx
lecture 4 Clinical pharmacokinetics.pptxWaqasAhmad535
油
This document provides an overview of clinical pharmacokinetics concepts. It defines key terms like pharmacokinetics, volume of distribution, clearance, and half-life. It describes pharmacokinetic processes like absorption, distribution, metabolism and excretion. It also discusses concentration versus time profiles for different drug administration routes and pharmacokinetic models like one compartment and two compartment models. The document aims to explain fundamental clinical pharmacokinetics principles and parameters.Oral sustained and controlled release dosage forms 
Oral sustained and controlled release dosage forms Dr Gajanan Sanap
油
This document discusses oral sustained and controlled release dosage forms. It begins with an introduction and overview of rationality in designing sustained release drug formulations. It defines sustained release as formulations that continuously release medication over an extended period after a single dose to achieve prolonged therapeutic effects. Controlled release aims to deliver drug at a predetermined rate for a specified time period to maintain constant drug levels. The document outlines the differences between controlled and sustained release. It discusses objectives and advantages of sustained release formulations as well as challenges and factors to consider in design.Sustined release and controlled release
Sustined release and controlled releaseBashant Kumar sah
油
This document provides an overview of a seminar on sustained release drug delivery systems. It discusses:
1. The introduction and concept of sustained release drug delivery, including the advantages of maintaining a constant drug level over time.
2. The differences between controlled release and sustained release, with controlled release providing precise control of drug release and sustained release prolonging drug levels for an extended time.
3. Some of the key factors that affect the formulation of oral sustained release drug delivery systems, including aqueous solubility, partition coefficient, drug pKa and ionization, stability, and biological considerations like absorption, distribution, and metabolism.Pocket Guide: Pharmacokinetics Made Easy - sample 
Pocket Guide: Pharmacokinetics Made Easy - sample McGraw-Hill Education ANZ- Medical
油
Pocket Guide: Pharmacokinetics Made Easy is the latest update of the popular Pharmacokinetics Made Easy. It is suitable for a wide audience including medical practitioners, health professionals, and students. The individual chapters were initially published as a series of articles in Australian Prescriber to assist practitioners in drug dosing and therapy. The physiological approach herein adopted addresses clinical issues in drug therapy and makes them directly applicable to practice situations.Crdds pp
Crdds ppSalwa Naeem
油
The document discusses biopharmaceutical and pharmacokinetic considerations in developing controlled release drug products. It defines controlled release as delivering a drug at a predetermined rate over a specified time period, while sustained release follows first-order kinetics and tries but does not always achieve zero-order kinetics. The document outlines factors like dose size, drug stability, solubility, and pharmacokinetics that must be considered for controlled release formulations. Developing controlled release products can provide benefits like improved patient compliance and comfort through reduced dosing frequency but also faces challenges like potential dose dumping and variable drug absorption.
GP-Bioavailability.pdf
GP-Bioavailability.pdfSanjayaManiDixit
油
General Pharmacology Lecture 際際滷s on Bioavailability and Bioequivalence by Sanjaya Mani Dixit Assistant Professor of Pharmacology at Kathmandu Medical College
Pharmacokinetics
PharmacokineticsUsha Prakash
油
Pharmacokinetics is the study of the movement of drugs within the body over time, including absorption, distribution, metabolism, and excretion. Key concepts in pharmacokinetics include volume of distribution, which represents the theoretical volume needed for the drug concentration to be uniform throughout the body; clearance, which is the volume of blood cleared of drug per unit time; and bioavailability, which represents the fraction of an administered dose that reaches systemic circulation. These pharmacokinetic parameters are used to determine dosing by calculating the loading dose based on volume of distribution and maintenance dose based on clearance.PHARMACY Bioavailability & Bioequivalance.ppt
PHARMACY Bioavailability & Bioequivalance.pptIBNSINA National Medical College
油
Animal models and natural products to investigate in vivo and in vitro antidiabetic.pdfArea under the curve- Dr ASHWIN R
Area under the curve- Dr ASHWIN Rashwin ravi
油
The document discusses area under the curve (AUC) as it relates to bioavailability and pharmacokinetics. It defines AUC as the definite integral of the plasma drug concentration-time curve, which provides a measure of total drug exposure. Various methods for calculating AUC are described, including trapezoidal rule, which divides the curve into trapezoids and sums their areas. Factors affecting bioavailability and AUC include drug properties, formulation, and patient factors. Clinical applications of AUC include toxicity assessment, bioequivalence studies, and pharmacokinetic dosing.Bioavailabilityand bioequivalence
Bioavailabilityand bioequivalenceharvestmoneyonline makemoney
油
This document provides information on bioavailability and bioequivalence. It defines bioavailability as the rate and extent of absorption of a drug that reaches systemic circulation in an active form. Bioequivalence exists when the bioavailability of a drug is the same between different formulations. The document discusses factors affecting bioavailability and various methods to assess bioavailability such as pharmacokinetic and urinary excretion methods. It also covers dissolution testing, limitations of assessing bioavailability and bioequivalence, and the need to conduct bioequivalence studies.Clinical pharmacology.Basics.
Clinical pharmacology.Basics.Eugene Shorikov
油
Clinical pharmacology studies how medications act in the human body. It has several key areas of focus: pharmacodynamics examines the effects of drugs and their mechanisms of action; pharmacokinetics studies how the body absorbs, distributes, metabolizes and eliminates drugs. Pharmacogenetics explores genetic factors influencing individual responses to medications. Receptors play an important role in how drugs produce their effects, and drugs can act through different receptor types or mechanisms to produce their intended or side effects.
Kinetika En 2002
Kinetika En 2002Flavio Guzm叩n
油
Pharmacokinetics is the study of drug absorption, distribution, metabolism, and excretion in the body. The key pharmacokinetic parameters include volume of distribution (Vd), clearance (CL), and elimination half-life (t1/2). Vd represents the apparent volume needed to contain the total amount of drug at the observed plasma concentration. CL is the volume of plasma cleared of drug per unit time, determined by metabolism and excretion. t1/2 is the time for drug concentration to reduce by half, dependent on Vd and CL. These parameters allow quantification of drug behavior in the body over time.Kinetika En 2002
Kinetika En 2002Flavio Guzm叩n
油
- Pharmacokinetics is the study of the absorption, distribution, metabolism, and excretion of drugs in the body over time. It aims to quantitatively account for the amount of drug in the body and the rate it is cleared.
- Distribution of drugs throughout tissues is affected by factors like membrane permeability, blood flow, lipid solubility, pH, and plasma protein binding. The apparent volume of distribution indicates how much volume a drug appears to distribute into based on its concentration in plasma.
- Clearance is the rate of drug elimination from plasma relative to its concentration and depends on hepatic and renal elimination. It is used to calculate maintenance dosing to achieve a target concentration.Solubilization in Pharmaceutical Sciences: Concepts, Mechanisms & Enhancement...
Solubilization in Pharmaceutical Sciences: Concepts, Mechanisms & Enhancement...KHUSHAL CHAVAN
油
This presentation provides an in-depth understanding of solubilization and its critical role in pharmaceutical formulations. It covers:
Definition & Mechanisms of Solubilization
Role of surfactants, micelles, and bile salts in drug solubility
Factors affecting solubilization (pH, polarity, particle size, temperature, etc.)
Methods to enhance drug solubility (Buffers, Co-solvents, Surfactants, Complexation, Solid Dispersions)
Advanced approaches (Polymorphism, Salt Formation, Co-crystallization, Prodrugs)
This resource is valuable for pharmaceutical scientists, formulation experts, regulatory professionals, and students interested in improving drug solubility and bioavailability.
More Related Content
Similar to dokumen.tips_parameter-farmakokinetik-5785c20de078f.ppt (20)
Chapter 4 BA.pptx for biopharmaceuticall
Chapter 4 BA.pptx for biopharmaceuticallShakirAliyi
油
Unfortunately I have all identity and no other means of doing so I will assume it means the risk of contracting disease X was the same for both sexes and the actual burden of the particular disease and the multifactorial model recognizes that most diseases are transmitted through the invasion and growth of specific pathogens in the body is to help maintain normal levels of fluid inside our cells Source of chloride the Western diet are sodium chloride and the multifactorial model recognizes that most diseases are transmitted through the invasion and growth of specific pathogens in the body is to help maintain normal levels of fluid inside our cells Source of chloride the Western diet are sodium chloride and the multifactorial model recognizes that most diseases are transmitted transmitted the the the the of specific pathogens in in body is to to maintain normal normal of of inside our our Source of chloride the Western Western are sodium sodium and the multifactorial model model that most diseases are transmitted transmitted transmitted transmitted transmitted transmitted of specific pathogens in the body is to help maintain normal levels of fluid inside our cells Source of chloride the Western diet are sodium chloride and the multifactorial model recognizes that most diseases are transmitted through the invasion and growth of specific pathogens in the body is to help maintain normal levels of fluid inside our cells Source of chloride the Western diet are sodium chloride and the multifactorial model recognizes that most diseases are transmitted through the invasion and growth of specific pathogens in the body Chapter 4 BA.biopharamaceutical ppt .com
Chapter 4 BA.biopharamaceutical ppt .comShakirAliyi
油
Heres a detailed breakdown of the sections of a business plan tailored specifically to an Oromia-themed restaurant and coffee shop:
---
### **1. Executive Summary**
**Purpose**: Provides a snapshot of the business idea and captures the interest of potential investors or stakeholders.
#### **Key Elements**:
- **Business Name**: Oromia Restaurant & Coffee Shop.
- **Mission Statement**: "To deliver an authentic Oromia cultural and culinary experience by offering high-quality traditional dishes and coffee in a welcoming atmosphere."
- **Business Goals**:
- Launch and establish a leading Oromia-themed restaurant and coffee shop within one year.
- Achieve monthly revenue growth of 15% within the first two years.
- **Target Audience**: Ethiopian diaspora, cultural enthusiasts, coffee lovers, and foodies seeking authentic Oromo cuisine.
- **Funding Requirements**: $200,000 for startup costs (kitchen equipment, interior design, marketing, and initial operations).
---
### **2. Business Description**
**Purpose**: Explains what the business is, its purpose, and its unique qualities.
#### **Key Elements**:
- **Industry Overview**: Focused on the Ethiopian culinary and hospitality industry, with special emphasis on Oromo culture and coffee traditions.
- **Business Concept**: A fusion of restaurant and coffee shop offering authentic Oromo dishes, specialty coffee ceremonies, and cultural performances.
- **Unique Selling Proposition (USP)**: A niche cultural dining experience combining Oromo cuisine, freshly roasted coffee, and immersive cultural elements like music and decor.
---
### **3. Market Analysis**
**Purpose**: Understands the market and identifies opportunities.
#### **Key Elements**:
- **Target Market**:
- Local residents in urban areas who appreciate diverse cuisines.
- Ethiopian/Oromo diaspora interested in cultural preservation.
- Tourists seeking authentic experiences.
- **Market Trends**:
- Growing interest in Ethiopian cuisine globally.
- Increasing demand for specialty coffee experiences.
- Cultural dining as a growing niche in the hospitality industry.
- **Competitor Analysis**:
- Competing restaurants: Focused on general Ethiopian dishes.
- Differentiation: Highlight unique Oromo flavors and traditional coffee ceremonies.
---
### **4. Organization and Management**
**Purpose**: Outlines the structure and key personnel.
#### **Key Elements**:
- **Ownership Structure**: Sole proprietorship or partnership owned by Oromo entrepreneurs.
- **Management Team**:
- General Manager: Overseeing operations and finance.
- Head Chef: Specializing in Oromo dishes.
- Barista Lead: Expert in coffee brewing and ceremony presentations.
- Marketing Manager: Focus on community outreach and promotions.
---
### **5. Products and Services**
**Purpose**: Describes the offerings in detail.
#### **Key Elements**:
- **Menu Items**:
- Signature Dishes: Injera with Chapter 4 biopharmaceutical and therapy ppt
Chapter 4 biopharmaceutical and therapy pptShakirAliyi
油
Of the findings of the distribution of a policy being made to the need of the key to be made to be removed enzymatically the information provided is the study is prevalence by the number to be scientific and used of its counterpart and its transmission of information to others and is also applicable laws to be scientific or used in accordance with metabolism and other legumes and other legumes and other legumes to make hemoglobin and all the group 3Bioavailability and bioequivalence of Drug Product.docx
Bioavailability and bioequivalence of Drug Product.docxabhisheksinghcompute
油
This document discusses bioavailability and bioequivalence of drug products. It defines bioavailability as the proportion of a drug that is absorbed and available systemically, and bioequivalence as assessing the expected in vivo equivalence of two drug preparations. Two products are considered bioequivalent if their bioavailability and effects are essentially the same. Pharmacokinetic methods like plasma level time studies and pharmacodynamic methods are used to measure bioavailability. Key parameters analyzed from plasma concentration-time curves include Cmax, Tmax, and AUC.BioavailabilityandBioequivalence.pdf
BioavailabilityandBioequivalence.pdfabhisheksinghcompute
油
This document discusses bioavailability and bioequivalence. It defines bioavailability as the rate and extent of absorption of an orally administered drug, which depends on factors like absorption and hepatic metabolism. Bioequivalence refers to similar bioavailability between formulations, and is determined by comparing AUC and Cmax values. The document outlines methods to assess bioavailability, including pharmacokinetic studies and dissolution testing, and factors that can influence bioavailability such as physiological, physicochemical, and pharmacological factors. It also discusses limitations of bioavailability and bioequivalence studies.lecture 4 Clinical pharmacokinetics.pptx
lecture 4 Clinical pharmacokinetics.pptxWaqasAhmad535
油
This document provides an overview of clinical pharmacokinetics concepts. It defines key terms like pharmacokinetics, volume of distribution, clearance, and half-life. It describes pharmacokinetic processes like absorption, distribution, metabolism and excretion. It also discusses concentration versus time profiles for different drug administration routes and pharmacokinetic models like one compartment and two compartment models. The document aims to explain fundamental clinical pharmacokinetics principles and parameters.Oral sustained and controlled release dosage forms
Oral sustained and controlled release dosage forms Dr Gajanan Sanap
油
This document discusses oral sustained and controlled release dosage forms. It begins with an introduction and overview of rationality in designing sustained release drug formulations. It defines sustained release as formulations that continuously release medication over an extended period after a single dose to achieve prolonged therapeutic effects. Controlled release aims to deliver drug at a predetermined rate for a specified time period to maintain constant drug levels. The document outlines the differences between controlled and sustained release. It discusses objectives and advantages of sustained release formulations as well as challenges and factors to consider in design.Sustined release and controlled release
Sustined release and controlled releaseBashant Kumar sah
油
This document provides an overview of a seminar on sustained release drug delivery systems. It discusses:
1. The introduction and concept of sustained release drug delivery, including the advantages of maintaining a constant drug level over time.
2. The differences between controlled release and sustained release, with controlled release providing precise control of drug release and sustained release prolonging drug levels for an extended time.
3. Some of the key factors that affect the formulation of oral sustained release drug delivery systems, including aqueous solubility, partition coefficient, drug pKa and ionization, stability, and biological considerations like absorption, distribution, and metabolism.Pocket Guide: Pharmacokinetics Made Easy - sample
Pocket Guide: Pharmacokinetics Made Easy - sample McGraw-Hill Education ANZ- Medical
油
Pocket Guide: Pharmacokinetics Made Easy is the latest update of the popular Pharmacokinetics Made Easy. It is suitable for a wide audience including medical practitioners, health professionals, and students. The individual chapters were initially published as a series of articles in Australian Prescriber to assist practitioners in drug dosing and therapy. The physiological approach herein adopted addresses clinical issues in drug therapy and makes them directly applicable to practice situations.Crdds pp
Crdds ppSalwa Naeem
油
The document discusses biopharmaceutical and pharmacokinetic considerations in developing controlled release drug products. It defines controlled release as delivering a drug at a predetermined rate over a specified time period, while sustained release follows first-order kinetics and tries but does not always achieve zero-order kinetics. The document outlines factors like dose size, drug stability, solubility, and pharmacokinetics that must be considered for controlled release formulations. Developing controlled release products can provide benefits like improved patient compliance and comfort through reduced dosing frequency but also faces challenges like potential dose dumping and variable drug absorption.GP-Bioavailability.pdf
GP-Bioavailability.pdfSanjayaManiDixit
油
General Pharmacology Lecture 際際滷s on Bioavailability and Bioequivalence by Sanjaya Mani Dixit Assistant Professor of Pharmacology at Kathmandu Medical College
Pharmacokinetics
PharmacokineticsUsha Prakash
油
Pharmacokinetics is the study of the movement of drugs within the body over time, including absorption, distribution, metabolism, and excretion. Key concepts in pharmacokinetics include volume of distribution, which represents the theoretical volume needed for the drug concentration to be uniform throughout the body; clearance, which is the volume of blood cleared of drug per unit time; and bioavailability, which represents the fraction of an administered dose that reaches systemic circulation. These pharmacokinetic parameters are used to determine dosing by calculating the loading dose based on volume of distribution and maintenance dose based on clearance.PHARMACY Bioavailability & Bioequivalance.ppt
PHARMACY Bioavailability & Bioequivalance.pptIBNSINA National Medical College
油
Animal models and natural products to investigate in vivo and in vitro antidiabetic.pdfArea under the curve- Dr ASHWIN R
Area under the curve- Dr ASHWIN Rashwin ravi
油
The document discusses area under the curve (AUC) as it relates to bioavailability and pharmacokinetics. It defines AUC as the definite integral of the plasma drug concentration-time curve, which provides a measure of total drug exposure. Various methods for calculating AUC are described, including trapezoidal rule, which divides the curve into trapezoids and sums their areas. Factors affecting bioavailability and AUC include drug properties, formulation, and patient factors. Clinical applications of AUC include toxicity assessment, bioequivalence studies, and pharmacokinetic dosing.Bioavailabilityand bioequivalence
Bioavailabilityand bioequivalenceharvestmoneyonline makemoney
油
This document provides information on bioavailability and bioequivalence. It defines bioavailability as the rate and extent of absorption of a drug that reaches systemic circulation in an active form. Bioequivalence exists when the bioavailability of a drug is the same between different formulations. The document discusses factors affecting bioavailability and various methods to assess bioavailability such as pharmacokinetic and urinary excretion methods. It also covers dissolution testing, limitations of assessing bioavailability and bioequivalence, and the need to conduct bioequivalence studies.Clinical pharmacology.Basics.
Clinical pharmacology.Basics.Eugene Shorikov
油
Clinical pharmacology studies how medications act in the human body. It has several key areas of focus: pharmacodynamics examines the effects of drugs and their mechanisms of action; pharmacokinetics studies how the body absorbs, distributes, metabolizes and eliminates drugs. Pharmacogenetics explores genetic factors influencing individual responses to medications. Receptors play an important role in how drugs produce their effects, and drugs can act through different receptor types or mechanisms to produce their intended or side effects.Kinetika En 2002
Kinetika En 2002Flavio Guzm叩n
油
Pharmacokinetics is the study of drug absorption, distribution, metabolism, and excretion in the body. The key pharmacokinetic parameters include volume of distribution (Vd), clearance (CL), and elimination half-life (t1/2). Vd represents the apparent volume needed to contain the total amount of drug at the observed plasma concentration. CL is the volume of plasma cleared of drug per unit time, determined by metabolism and excretion. t1/2 is the time for drug concentration to reduce by half, dependent on Vd and CL. These parameters allow quantification of drug behavior in the body over time.Kinetika En 2002
Kinetika En 2002Flavio Guzm叩n
油
- Pharmacokinetics is the study of the absorption, distribution, metabolism, and excretion of drugs in the body over time. It aims to quantitatively account for the amount of drug in the body and the rate it is cleared.
- Distribution of drugs throughout tissues is affected by factors like membrane permeability, blood flow, lipid solubility, pH, and plasma protein binding. The apparent volume of distribution indicates how much volume a drug appears to distribute into based on its concentration in plasma.
- Clearance is the rate of drug elimination from plasma relative to its concentration and depends on hepatic and renal elimination. It is used to calculate maintenance dosing to achieve a target concentration.Recently uploaded (20)
Solubilization in Pharmaceutical Sciences: Concepts, Mechanisms & Enhancement...
Solubilization in Pharmaceutical Sciences: Concepts, Mechanisms & Enhancement...KHUSHAL CHAVAN
油
This presentation provides an in-depth understanding of solubilization and its critical role in pharmaceutical formulations. It covers:
Definition & Mechanisms of Solubilization
Role of surfactants, micelles, and bile salts in drug solubility
Factors affecting solubilization (pH, polarity, particle size, temperature, etc.)
Methods to enhance drug solubility (Buffers, Co-solvents, Surfactants, Complexation, Solid Dispersions)
Advanced approaches (Polymorphism, Salt Formation, Co-crystallization, Prodrugs)
This resource is valuable for pharmaceutical scientists, formulation experts, regulatory professionals, and students interested in improving drug solubility and bioavailability.
Optimization in Pharmaceutical Formulations: Concepts, Methods & Applications
Optimization in Pharmaceutical Formulations: Concepts, Methods & ApplicationsKHUSHAL CHAVAN
油
This presentation provides a comprehensive overview of optimization in pharmaceutical formulations. It explains the concept of optimization, different types of optimization problems (constrained and unconstrained), and the mathematical principles behind formulation development. Key topics include:
Methods for optimization (Sequential Simplex Method, Classical Mathematical Methods)
Statistical analysis in optimization (Mean, Standard Deviation, Regression, Hypothesis Testing)
Factorial Design & Quality by Design (QbD) for process improvement
Applications of optimization in drug formulation
This resource is beneficial for pharmaceutical scientists, R&D professionals, regulatory experts, and students looking to understand pharmaceutical process optimization and quality by design approaches.Best Sampling Practices Webinar USP <797> Compliance & Environmental Monito...
Best Sampling Practices Webinar USP <797> Compliance & Environmental Monito...NuAire
油
Best Sampling Practices Webinar USP <797> Compliance & Environmental Monitoring
Are your cleanroom sampling practices USP <797> compliant? This webinar, hosted by Pharmacy Purchasing & Products (PP&P Magazine) and sponsored by NuAire, features microbiology expert Abby Roth discussing best practices for surface & air sampling, data analysis, and compliance.
Key Topics Covered:
鏝 Viable air & surface sampling best practices
鏝 USP <797> requirements & compliance strategies
鏝 How to analyze & trend viable sample data
鏝 Improving environmental monitoring in cleanrooms
･ Watch Now: https://www.nuaire.com/resources/best-sampling-practices-cleanroom-usp-797
Stay informedfollow Abby Roth on LinkedIn for more cleanroom insights!
ISPE Baseline PEG Volumen 7 Risk-Based Manufacture Pharmaceutical Products 2n...
ISPE Baseline PEG Volumen 7 Risk-Based Manufacture Pharmaceutical Products 2n...alokksharma18
油
guidelines for pharma productsPERSONALITY DEVELOPMENT & DEFENSE MECHANISMS.pptxPersonality and environment:...
PERSONALITY DEVELOPMENT & DEFENSE MECHANISMS.pptxPersonality and environment:...ABHAY INSTITUTION
油
Personality theory is a collection of ideas that explain how a person's personality develops and how it affects their behavior. It also seeks to understand how people react to situations, and how their personality impacts their relationships.
Key aspects of personality theory
Personality traits: The characteristics that make up a person's personality.
Personality development: How a person's personality develops over time.
Personality disorders: How personality theories can be used to study personality disorders.
Personality and environment: How a person's personality is influenced by their environment. Renal Physiology - Regulation of GFR and RBF
Renal Physiology - Regulation of GFR and RBFMedicoseAcademics
油
1. Explain the physiological control of glomerular filtration and renal blood flow
2. Describe the humoral and autoregulatory feedback mechanisms that mediate the autoregulation of renal plasma flow and glomerular filtration rate
BIOMECHANICS OF THE MOVEMENT OF THE SHOULDER COMPLEX.pptx
BIOMECHANICS OF THE MOVEMENT OF THE SHOULDER COMPLEX.pptxdrnidhimnd
油
The shoulder complex acts as in coordinated fashion to provide the smoothest and greatest range of motion possible of the upper limb.
Combined motion of GH and ST joint of shoulder complex helps in:
Distribution of motion between other two joints.
Maintenance of glenoid fossa in optimal position.
Maintenance of good length tension
Although some amount of glenohumeral motion may occur while the other shoulder articulations remain stabilized, movement of the humerus more commonly involves some movement at all three shoulder joints.
Stability of Dosage Forms as per ICH Guidelines
Stability of Dosage Forms as per ICH GuidelinesKHUSHAL CHAVAN
油
This presentation covers the stability testing of pharmaceutical dosage forms according to ICH guidelines (Q1A-Q1F). It explains the definition of stability, various testing protocols, storage conditions, and evaluation criteria required for regulatory submissions. Key topics include stress testing, container closure systems, stability commitment, and photostability testing. The guidelines ensure that pharmaceutical products maintain their identity, purity, strength, and efficacy throughout their shelf life. This resource is valuable for pharmaceutical professionals, researchers, and regulatory experts.IMMUNO-ONCOLOGY DESCOVERING THE IMPORTANCE OF CLINICAL IMUNOLOGY IN MEDICINE
IMMUNO-ONCOLOGY DESCOVERING THE IMPORTANCE OF CLINICAL IMUNOLOGY IN MEDICINERelianceNwosu
油
This presentation emphasizes the role of immunodiagnostics and Immunotherapy. DIAGNOSIS OF PREGNANCY PPT IN ALL TRIMESTER
DIAGNOSIS OF PREGNANCY PPT IN ALL TRIMESTERdaminipatel37
油
Diagnosis of all three trimester of pregnancy 
SAPIENT Medi-trivia Quiz (FINALS) | TRI-ORTA 2025
SAPIENT Medi-trivia Quiz (FINALS) | TRI-ORTA 2025Dr. Anindya
油
Final Round of SAPIENT Medi-trivia quiz
Part of TRI-ORTA 2025
Venue: GLT, Medical College Kolkata
Date: 25-02-2025Acute & Chronic Inflammation, Chemical mediators in Inflammation and Wound he...
Acute & Chronic Inflammation, Chemical mediators in Inflammation and Wound he...Ganapathi Vankudoth
油
A complete information of Inflammation, it includes types of Inflammation, purpose of Inflammation, pathogenesis of acute inflammation, chemical mediators in inflammation, types of chronic inflammation, wound healing and Inflammation in skin repair, phases of wound healing, factors influencing wound healing and types of wound healing.The influence of birth companion in mother care and neonatal outcome
The influence of birth companion in mother care and neonatal outcomeLokesh Kumar Sharma
油
this content related to birth companionship, role of birth companion in care of mother and neonatal Multimodal Approaches to Clitoral Augmentation for FGM (PRP _ filler)"
Multimodal Approaches to Clitoral Augmentation for FGM (PRP _ filler)"Rehab Aboshama
油
Multimodal Approaches to Clitoral Augmentation for FGM (PRP _ filler)"
Acute & Chronic Inflammation, Chemical mediators in Inflammation and Wound he...
Acute & Chronic Inflammation, Chemical mediators in Inflammation and Wound he...Ganapathi Vankudoth
油
dokumen.tips_parameter-farmakokinetik-5785c20de078f.ppt
- 1. PERAN PARAMETER FARMAKOKINETIK DALAM TERAPI Mata Kuliah : Farmakokinetik Dosen Pengampu : Rovina Ruslami, dr., SpPD, PhD Oleh : Neni Anggraeni (130120150011)
- 2. Parameter farmakokinetika adalah besaran yang diturunkan secara matematis dari model yang berdasarkan hasil pengukuran kadar obat utuh atau metabolitnya dalam darah, urin atau cairan hayati lainya. Parameter farmakokinetik suatu obat ini dapat digunakan untuk memperoleh gambaran dan mempelajari suatu kinetika absorpsi, distribusi dan eliminasi didalam tubuh.
- 3. Volume Of Distribution Volume of distribution (V) relates the amount of drug in the body to the concentration of drug (C) in blood or plasma: Volume distribusi dapat berubah karena umur, jenis kelamin, dan penyakit Obat yg terikat dgn protein plasma, sebagian besar obat berada didalam darah maka volume distribusinya akan mempunyai batas terendah. (warfarin & klorpropamid)
- 4. Clearance Drug clearance principles are similar to the clearance concepts of renal physiology. Clearance of a drug is the factor that predicts the rate of elimination in relation to the drug concentration (C) Clearance, like volume of distribution, may be defined with respect to blood (CLb), plasma (CLp), or unbound in water (CLu), depending on where and how the concentration is measured.
- 5. Clearance Elimination of drug from the body may involve processes occurring in the kidney, the lung, the liver, and other organs.
- 6. Clearance Capacity-Limited Elimination Most drug elimination pathways will become saturated if the dose and therefore the concentration are high enough. When blood flow to an organ does not limit elimination, the relation between elimination rate and concentration (C) :
- 7. Half Life Half-life (t1 /2) is the time required to change the amount of drug in the body by one-half during elimination (or during a constant infusion). The time course of drug in the body will depend on both the volume of distribution and the clearance:
- 9. A RATIONAL DOSAGE REGIMEN A rational dosage regimen is based on the assumption that there is a target concentration that will produce the desired therapeutic effect. Penentuan Dosis berdasarkan : Jumlah obat yang diberikan dalam satu waktu Cara pemberian Jarak waktu diantara dua dosis Lama waktu pemberian obat
- 10. Maintenance Dose At steady state, the dosing rate (rate in) must equal the rate of elimination (rate out). Substitution of the target concentration (TC) for concentration (C) in equation predicts the maintenance dosing rate: Maintance Dose = Dosing rate x Dosing interval
- 11. Loading Dose The volume of distribution is the proportionality factor that relates the total amount of drug in the body to the concentration; if a loading dose is to achieve the target concentration
- 12. Efek Penyakit Terhadap Proses Farmakokinetik Keadaan patologis dapat merubah semua parameter farmakokinetik Umumnya kelainan hati dapat mengurangi clearance dan memprlama half time obat. Tetapi pada obat-obat tertentu terjadi sebaliknya. Contoh : tolbutamid pada penyakit hepaitis virus akut. Perubahan farmakokinetik pada penyakit ginjal dapat diterangkan dengan konsep clearance. Cl ginjal = (Cl RF + Cl RS) x (1-FR) Ekskresi ginjal di tentukan oleh Filtrasi, sekresi aktif, dan reabsorpsi. Filtrasi : Volume cairan yg difiltrasi & konsentrasi obat yg tidak terikat didalam plasma.